Brokerages Set National Health Investors, Inc. (NYSE:NHI) Price Target at $70.86

National Health Investors, Inc. (NYSE:NHIGet Free Report) has been assigned an average rating of “Moderate Buy” from the seven ratings firms that are presently covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $73.29.

Several research firms have commented on NHI. Truist Financial raised their target price on shares of National Health Investors from $65.00 to $78.00 and gave the company a “hold” rating in a report on Friday, August 30th. Wells Fargo & Company cut National Health Investors from an “overweight” rating to an “equal weight” rating and upped their target price for the stock from $81.00 to $86.00 in a research note on Tuesday. Bank of America started coverage on National Health Investors in a report on Tuesday, September 24th. They issued a “buy” rating and a $92.00 target price on the stock. Finally, StockNews.com raised National Health Investors from a “hold” rating to a “buy” rating in a report on Thursday, August 8th.

Get Our Latest Analysis on NHI

National Health Investors Trading Down 0.9 %

Shares of NHI stock opened at $81.63 on Friday. The stock has a market cap of $3.54 billion, a P/E ratio of 26.70, a price-to-earnings-growth ratio of 8.86 and a beta of 1.04. National Health Investors has a 1 year low of $48.51 and a 1 year high of $86.13. The company has a current ratio of 10.27, a quick ratio of 10.27 and a debt-to-equity ratio of 0.91. The stock has a 50 day simple moving average of $79.37 and a 200 day simple moving average of $70.20.

National Health Investors (NYSE:NHIGet Free Report) last released its earnings results on Tuesday, August 6th. The real estate investment trust reported $0.81 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.10 by ($0.29). The company had revenue of $84.97 million for the quarter, compared to analyst estimates of $64.95 million. National Health Investors had a return on equity of 10.11% and a net margin of 39.11%. The business’s revenue for the quarter was up 9.1% compared to the same quarter last year. During the same period last year, the company posted $1.06 earnings per share. On average, research analysts predict that National Health Investors will post 4.55 earnings per share for the current fiscal year.

National Health Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Investors of record on Friday, September 27th will be given a dividend of $0.90 per share. The ex-dividend date is Friday, September 27th. This represents a $3.60 dividend on an annualized basis and a yield of 4.41%. National Health Investors’s dividend payout ratio is currently 118.03%.

Hedge Funds Weigh In On National Health Investors

Several large investors have recently bought and sold shares of the company. Norges Bank acquired a new position in shares of National Health Investors in the fourth quarter valued at approximately $25,448,000. Land & Buildings Investment Management LLC increased its position in National Health Investors by 81.8% in the 4th quarter. Land & Buildings Investment Management LLC now owns 412,052 shares of the real estate investment trust’s stock valued at $23,013,000 after acquiring an additional 185,377 shares during the period. Sound Income Strategies LLC raised its stake in shares of National Health Investors by 21,963.3% during the second quarter. Sound Income Strategies LLC now owns 153,119 shares of the real estate investment trust’s stock valued at $10,371,000 after acquiring an additional 152,425 shares during the last quarter. Lee Danner & Bass Inc. acquired a new position in shares of National Health Investors during the second quarter worth $5,089,000. Finally, Sumitomo Mitsui Trust Holdings Inc. grew its stake in shares of National Health Investors by 16.0% in the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 472,959 shares of the real estate investment trust’s stock worth $32,034,000 after purchasing an additional 65,104 shares during the last quarter. 62.51% of the stock is currently owned by institutional investors.

National Health Investors Company Profile

(Get Free Report

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

Further Reading

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.